Stockscreener 앱 받기
6.03
65.66%
2.39
시간 외 거래:
6.20
0.17
+2.82%
전일 마감가:
$3.64
열려 있는:
$6.97
하루 거래량:
55.65M
Relative Volume:
56.84
시가총액:
$7.07M
수익:
-
순이익/손실:
$-11.46M
주가수익비율:
-0.4307
EPS:
-14
순현금흐름:
$-24.56M
1주 성능:
+95.15%
1개월 성능:
+34.78%
6개월 성능:
-59.29%
1년 성능:
-88.68%
1일 변동 폭
$4.81
$9.80
1주일 범위
$2.38
$9.80
52주 변동 폭
$2.38
$53.45
에바종 바이오테크 Stock (EVAX) Company Profile
EVAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVAX
Evaxion Biotech A S Adr
|
6.03 | 7.07M | 0 | -11.46M | -24.56M | -14.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
439.62 | 113.22B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
675.79 | 74.26B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
648.94 | 38.80B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
278.76 | 35.95B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.14 | 28.32B | 3.30B | -501.07M | 1.03B | -2.1146 |
에바종 바이오테크 Stock (EVAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-02 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2024-02-12 | 개시 | H.C. Wainwright | Buy |
에바종 바이오테크 주식(EVAX)의 최신 뉴스
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gains 2% for Week - MSN
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading - MSN
Evaxion Biotech stock hits 52-week low at $3.06 amid sharp decline By Investing.com - Investing.com South Africa
Evaxion Biotech stock hits 52-week low at $3.06 amid sharp decline - Investing.com
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading - MSN
Evaxion Biotech stock hits 52-week low at $0.81 amid market challenges - Investing.com India
Evaxion announces extension to January 14, 2025, of plan to implement ADS ratio change - GlobeNewswire Inc.
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Flat for Week - MSN
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - MSN
Evaxion Biotech Announces 1:5 ADS Ratio Change, Effective January 2025 - StockTitan
European Equities Traded in the US as American Depositary Rise in Monday Trading - MSN
European Equities Traded in the US as American Depositary Rise in Thursday Trading - MSN
European Equities Traded in US as American Depositary Receipts Tread Water Friday, Up 3% for Week - MSN
European Equities Traded in the US as American Depositary Edge Higher in Thursday Trading - MSN
Evaxion Biotech stock hits 52-week low at $0.84 amid market challenges - Investing.com
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading - MSN
European Equities Traded in the US as American Depositary Fall in Wednesday Trading - MSN
Evaxion Biotech stock hits 52-week low at $0.92 - Investing.com
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Down 1.5% for Week - MSN
European Equities Traded in the US as American Depositary Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading - MSN
Evaxion achieves preclinical success with AI cancer vaccine - Investing.com
Evaxion Biotech stock hits 52-week low at $1.19 - Investing.com
European Equities Traded in the US as American Depositary Receipts Nudge Higher Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Edge Higher in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Flat in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
Evaxion Biotech stock hits 52-week low at $1.31 By Investing.com - Investing.com South Africa
Evaxion Biotech stock hits 52-week low at $1.31 - Investing.com
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower - MSN
European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Move Higher in Monday Trading - MSN
European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week - MSN
Evaxion appeals Nasdaq delisting determination - Investing.com
European Equities Traded in the US as American Depositary Receipts Rise Sharply Friday, Up 2.7% for Week - MSN
European Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note Friday - MSN
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Monday Trading - MSN
Evaxion Biotech Reports Q3 Progress and Financials - TipRanks
European Equities Traded in the US as American Depositary Receipts Edge Lower Friday; Set to End Week Up 0.5% - MSN
European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Slightly Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading - MSN
에바종 바이오테크 (EVAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
25.79%
2.31%
자본화:
|
볼륨(24시간):